These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8826850)

  • 1. High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor.
    White GR; Stack M; Santibáñez-Koref M; Liscia DS; Venesio T; Wang JC; Helms C; Donis-Keller H; Betticher DC; Altermatt HJ; Hoban PR; Heighway J
    Br J Cancer; 1996 Sep; 74(6):863-70. PubMed ID: 8826850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
    Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
    Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1.
    Godwin AK; Vanderveer L; Schultz DC; Lynch HT; Altomare DA; Buetow KH; Daly M; Getts LA; Masny A; Rosenblum N
    Am J Hum Genet; 1994 Oct; 55(4):666-77. PubMed ID: 7942844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith-Magenis region, an unstable region in chromosome band 17p11.2.
    Scheurlen WG; Seranski P; Mincheva A; Kühl J; Sörensen N; Krauss J; Lichter P; Poustka A; Wilgenbus KK
    Genes Chromosomes Cancer; 1997 Jan; 18(1):50-8. PubMed ID: 8993980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
    Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
    Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
    Matsumura K; Kallioniemi A; Kallioniemi O; Chen L; Smith HS; Pinkel D; Gray J; Waldman FM
    Cancer Res; 1992 Jun; 52(12):3474-7. PubMed ID: 1350754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas.
    Wu JK; Darras BT
    Neurol Res; 1992 Mar; 14(1):39-44. PubMed ID: 1351257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.
    Chen LC; Neubauer A; Kurisu W; Waldman FM; Ljung BM; Goodson W; Goldman ES; Moore D; Balazs M; Liu E
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3847-51. PubMed ID: 1673792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms.
    Dockhorn-Dworniczak B; Poremba C; Dantcheva R; Stücker A; Brömmelkamp E; Blasius S; Mellin W; Roessner A; Yandell DW; Böcker W
    Virchows Arch; 1994; 424(4):337-42. PubMed ID: 7911380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity on 17p in human breast carcinomas: defining the smallest common region of deletion.
    Devilee P; Cornelisse CJ; Kuipers-Dijkshoorn N; Jonker C; Pearson PL
    Cytogenet Cell Genet; 1990; 53(1):52-4. PubMed ID: 1969789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas.
    Merlo GR; Venesio T; Bernardi A; Cropp CS; Diella F; Cappa AP; Callahan R; Liscia DS
    Cancer Genet Cytogenet; 1994 Sep; 76(2):106-11. PubMed ID: 7923057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas.
    Park SY; Kang YS; Kim BG; Lee SH; Lee ED; Lee KH; Park KB; Lee JH
    Cancer Genet Cytogenet; 1995 Jan; 79(1):74-8. PubMed ID: 7850756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3.
    Stack M; Jones D; White G; Liscia DS; Venesio T; Casey G; Crichton D; Varley J; Mitchell E; Heighway J
    Hum Mol Genet; 1995 Nov; 4(11):2047-55. PubMed ID: 8589680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.
    Beghelli S; Pelosi G; Zamboni G; Falconi M; Iacono C; Bordi C; Scarpa A
    J Pathol; 1998 Sep; 186(1):41-50. PubMed ID: 9875139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis on loss of heterozygosity of chromosome 17p13.3 in hepatocellular carcinoma and construction of genomic contig in the deleted region].
    Zhao X; Wan D; Jiang H
    Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):377-80. PubMed ID: 11778272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
    Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
    Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
    Knowles MA; Shaw ME; Proctor AJ
    Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S
    Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.